Management Challenges of Low Grade Serous Ovarian/Peritoneal Cancer - David Gershenson

Low-grade serous ovarian cancer: expert consensus report on the state of the science video podcastПодробнее

Latest updates in low grade serous ovarian cancer treatment and researchПодробнее

Dr Gershenson on the discovery of borderline tumours and low-grade serous carcinomaПодробнее

Promising Advances in Low Grade Serous Ovarian CancerПодробнее

David Gershenson, MD, elaborates on the role of MEK inhibitor trametinib in LGSCПодробнее

Low-Grade Serous Ovarian CancerПодробнее

Lowdown on Low Grade Serous Ovarian Cancer: Learn The LatestПодробнее

OC 360 LIVE: Dr. David GershensonПодробнее

David Gershenson, MD, on considerations for maintenance therapy in ovarian cancerПодробнее

Is Trametinib a New Standard for Low-Grade Serous Ovarian Cancer?Подробнее

What’s the Latest in Low-Grade Serous Ovarian Cancer?Подробнее

Low-grade serous ovarian cancer research with Dr GershensonПодробнее

Low grade serous ovarian cancerПодробнее

Rare Ovarian Cancers: Highlights You Need To KnowПодробнее

Research Update on Recurrent Low-Grade Serous Ovarian CancerПодробнее

Management of low-grade serous carcinoma - Prof. Nicolo BizzarriПодробнее